BWL
GMAB icon

Bogart Wealth LLC’s Genmab GMAB Stock Holding History

Bogart Wealth LLC’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$110 Sell
4
-142
-97% -$3.77K ﹤0.01% 1932
2026
Q1 		$3.92K Hold
146
– – ﹤0.01% 1127
2025
Q4 		$4.5K Hold
146
– – ﹤0.01% 1023
2025
Q3 		$4.48K Hold
146
– – ﹤0.01% 999
2025
Q2 		$3.02K Hold
146
– – ﹤0.01% 1036
2025
Q1 		$2.86K Hold
146
– – ﹤0.01% 1014
2024
Q4 		$3.05K Hold
146
– – ﹤0.01% 1011
2024
Q3 		$3.56K Buy
+146
New +$3.9K ﹤0.01% 890
2024
Q1 		– Sell
-50
Closed -$1.59K – 1092
2023
Q4 		$1.59K Hold
50
– – ﹤0.01% 918
2023
Q3 		$1.76K Buy
+50
New +$1.91K ﹤0.01% 897

Other funds holding GMAB

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Bogart Wealth LLC's GMAB Position: Q2 2026 in Review

Bogart Wealth LLC reduced its Genmab (GMAB) stake by 97% in Q2 2026, selling an estimated $3.77K and leaving 4 shares worth $110. The position accounts for ﹤0.01% of the portfolio, ranked #1932.

Bogart Wealth LLC first reported a position in GMAB in Q3 2023 and has held it in 10 quarters since. The position peaked at $4.5K in Q4 2025. 290 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • Bogart Wealth LLC held 4 shares of Genmab worth $110 as of Q2 2026.
  • Bogart Wealth LLC sold 142 Genmab shares in Q2 2026, an estimated $3.77K.
  • Genmab made up ﹤0.01% of Bogart Wealth LLC's portfolio in Q2 2026, its #1932 holding.
  • Bogart Wealth LLC first reported a position in Genmab in Q3 2023 and has held it in 10 quarters since.
  • Bogart Wealth LLC's Genmab position peaked at $4.5K in Q4 2025.
  • 290 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on Bogart Wealth LLC's 13F filing for Q2 2026, filed 24 Jul 2026.